Literature DB >> 10193929

Mechanisms initiating lung injury in the preterm.

A H Jobe1, M Ikegami.   

Abstract

Bronchopulmonary dysplasia (BPD)/chronic lung disease occurs primarily in very low birth weight infants (VLBW) often without antecedent severe respiratory distress syndrome. The BPD in these VLBW infants results in less fibrosis than the traditional BPD but the normal process of alveolarization seems to be disrupted. This review develops the thesis that BPD in VLBW infants results from inflammatory mediators interfering with the signaling required for normal late gestational lung development. Proinflammatory mediators may be elevated because of fetal exposure, postnatal infection or by release from preterm lungs ventilated at either low or high lung volumes. The preterm lung is highly susceptible to injury during resuscitation or more chronic mechanical ventilation because the gas volumes/kg body weight of the lungs are small. An understanding of what causes cytokine release and how cytokines influence lung development is necessary to develop targeted therapies to minimize BPD. However, care strategies that minimize inflammation and ventilator-induced lung injury should help decrease BPD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10193929     DOI: 10.1016/s0378-3782(98)00045-0

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  71 in total

1.  Early use of high frequency ventilation in the premature neonate.

Authors:  Patrick Van Reempts; Christel Borstlap; Sabine Laroche; Jean-Claude Van der Auwera
Journal:  Eur J Pediatr       Date:  2003-02-04       Impact factor: 3.183

2.  Incomplete protection by prophylactic surfactant against the adverse effects of large lung inflations at birth in immature lambs.

Authors:  Jónas Ingimarsson; Lars J Björklund; Tore Curstedt; Saemundur Gudmundsson; Anders Larsson; Bengt Robertson; Olof Werner
Journal:  Intensive Care Med       Date:  2004-03-25       Impact factor: 17.440

3.  Infection with Ureaplasma urealyticum: is there a specific clinical and radiological course in the preterm infant?

Authors:  U Theilen; A J Lyon; T Fitzgerald; G M A Hendry; J W Keeling
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

Review 4.  Postnatal steroid treatment and brain development.

Authors:  O Baud
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

5.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia.

Authors:  Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

6.  Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines.

Authors:  J Davin Miller; John T Benjamin; David R Kelly; David B Frank; Lawrence S Prince
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-19       Impact factor: 5.464

7.  Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates.

Authors:  G Bokodi; L Derzbach; I Bányász; T Tulassay; B Vásárhelyi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-06-05       Impact factor: 5.747

Review 8.  Contribution of inflammation to lung injury and development.

Authors:  S G Kallapur; A H Jobe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03       Impact factor: 5.747

9.  The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase (PC-SOD) in man.

Authors:  F J F Broeyer; B E van Aken; J Suzuki; M J B Kemme; H C Schoemaker; A F Cohen; Y Mizushima; J Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2007-07-04       Impact factor: 4.335

Review 10.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.